Day 2 Highlights - ACC.19

2 years 13 Views


Drs. Kim Eagle, Deepak Bhatt, and Peter Block discuss TAVR vs. SAVR in low-risk patients (PARTNER 3 and Evolut Low Risk - 00:39); safety evaluation of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with AFib and ACS and/or PCI (AUGUSTUS - 2:55); partial oral treatment of left-sided infectious endocarditis (POET - 4:16); and a multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3 - 6:25). Visit for full meeting coverage.